 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

In the second quarter of FY24, the Pharma stocks saw strong revenue growth of 14.3% year-over-year and 1.7% quarter-over-quarter

Nifty Pharma scales record highs, rises in 14 out of 17 straight sessions

GlaxoSmithKline Standalone September 2023 Net Sales at Rs 953.38 crore, up 5.27% Y-o-Y

Glaxosmithkline Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quoting at Rs 1435.55, up 1.51% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.2% on the day, quoting at 19308.05. The Sensex is at 65001.66, down 0.13%. Glaxosmithkline Pharmaceuticals Ltd has added around 2.17% in last one month. Meanwhile, Nifty Metal index of which Glaxosmithkline Pharmaceuticals Ltd is a constituent, has added around 0.52% in last one month and is currently quoting at 15125.5, down 0.3% on the day. The volume in the stock stood at 97254 shares today, compared to the daily average of 54991 shares in last one month.The PE of the stock is 39.37 based on TTM earnings ending June 23.

Glaxosmithkline Pharmaceuticals Ltd spurts 1.51%, rises for third straight session

GlaxoSmithKline Consolidated June 2023 Net Sales at Rs 761.66 crore, up 2.22% Y-o-Y

GlaxoSmithKline Standalone June 2023 Net Sales at Rs 738.02 crore, up 1.17% Y-o-Y

GlaxoSmithKline Standalone March 2023 Net Sales at Rs 782.16 crore, down 1.23% Y-o-Y

GlaxoSmithKline Consolidated March 2023 Net Sales at Rs 787.45 crore, down 2.74% Y-o-Y

GlaxoSmithKline Standalone December 2022 Net Sales at Rs 799.11 crore, down 1.1% Y-o-Y

GlaxoSmithKline Consolidated December 2022 Net Sales at Rs 802.30 crore, down 1.67% Y-o-Y

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 February 2023.

GlaxoSmithKline Pharmaceuticals to conduct board meeting

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The vaccines products include prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. The company was founded in 1924 and is headquartered in Mumbai, India.

Watchers	106
52-Wk Low	1,227.00
52-Wk High	1,739.75

Market Cap	286.1B
Volume (M)	161,953.00
52-Wk High	1,739.75
52-Wk Low	1,227.00

Current Price	1,688.85
Prev Close	1,686.35
Open	1,694.80
Dividend Yield	2.42%
50-Day Moving Average	1,542.23
Beta	0.03
Avg. Volume	207,519.10
PE Ratio	44.17

52-Week High	1,739.75
52-Week Low	1,227.00
Market Capitalization	286.1B
EPS	38.24
Price to Book	18.58
Revenue Per Employee	8.99M
Enterprise Value/EBITDA	29.55

GLAXO.NSE GlaxoSmithkline Pharmaceuticals Ltd

About

Feed

News

Sentiment

Fundamentals